Dimensional Fund Advisors
FBRX icon

Dimensional Fund Advisors’s Forte Biosciences FBRX Stock Holding History

Dimensional Fund Advisors’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,765
Closed -$161K – 3268
2025
Q3 		$161K Buy
+10,765
New +$124K ﹤0.01% 3147
2019
Q4 		– Sell
-86
Closed -$21K – 3391
2019
Q3 		$21K Sell
86
-83
-49% -$126K ﹤0.01% 3410
2019
Q2 		$424K Buy
169
+87
+106% +$258K ﹤0.01% 3218
2019
Q1 		$336K Hold
82
– – ﹤0.01% 3229
2018
Q4 		$253K Hold
82
– – ﹤0.01% 3252
2018
Q3 		$481K Buy
+82
New +$312K ﹤0.01% 3187

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Dimensional Fund Advisors's FBRX Position: Q4 2025 in Review

Dimensional Fund Advisors sold out of Forte Biosciences (FBRX) in Q4 2025, closing a stake of 10,765 shares — an estimated $161K sold.

Dimensional Fund Advisors first reported a position in FBRX in Q3 2018 and held it in 6 quarters. The position peaked at $481K in Q3 2018. 59 funds tracked by Wall St. Rank hold FBRX as of Q4 2025.

  • Dimensional Fund Advisors reported no remaining Forte Biosciences position as of Q4 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 10,765 Forte Biosciences shares in Q4 2025, an estimated $161K.
  • Dimensional Fund Advisors first reported a position in Forte Biosciences in Q3 2018 and held it in 6 quarters.
  • Dimensional Fund Advisors's Forte Biosciences position peaked at $481K in Q3 2018.
  • 59 funds tracked by Wall St. Rank held Forte Biosciences as of Q4 2025.

Based on Dimensional Fund Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.